Technical Analysis for VRDN - Viridian Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bullish Engulfing | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Volume Surge | Other | 1.46% | |
Inside Day | Range Contraction | 1.46% | |
Lower Bollinger Band Touch | Weakness | 1.46% | |
Oversold Stochastic | Weakness | 1.46% | |
Stochastic Reached Oversold | Weakness | 0.52% |
Alert | Time |
---|---|
Up 3% | about 10 hours ago |
Up 2% | about 11 hours ago |
Up 1% | about 11 hours ago |
60 Minute Opening Range Breakout | about 12 hours ago |
Lower Bollinger Band Support | about 12 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/06/2024
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado, with research and development operations in Waltham, Massachusetts.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 30.3 |
52 Week Low | 10.925 |
Average Volume | 1,000,214 |
200-Day Moving Average | 18.85 |
50-Day Moving Average | 19.49 |
20-Day Moving Average | 18.66 |
10-Day Moving Average | 18.20 |
Average True Range | 1.28 |
RSI (14) | 42.53 |
ADX | 15.01 |
+DI | 14.05 |
-DI | 23.72 |
Chandelier Exit (Long, 3 ATRs) | 17.62 |
Chandelier Exit (Short, 3 ATRs) | 20.00 |
Upper Bollinger Bands | 20.46 |
Lower Bollinger Band | 16.86 |
Percent B (%b) | 0.13 |
BandWidth | 19.27 |
MACD Line | -0.47 |
MACD Signal Line | -0.29 |
MACD Histogram | -0.178 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 19.53 | ||||
Resistance 3 (R3) | 19.38 | 18.50 | 19.17 | ||
Resistance 2 (R2) | 18.50 | 17.94 | 18.58 | 19.04 | |
Resistance 1 (R1) | 17.92 | 17.60 | 18.21 | 18.07 | 18.92 |
Pivot Point | 17.04 | 17.04 | 17.19 | 17.12 | 17.04 |
Support 1 (S1) | 16.46 | 16.48 | 16.75 | 16.61 | 15.76 |
Support 2 (S2) | 15.58 | 16.14 | 15.66 | 15.64 | |
Support 3 (S3) | 15.00 | 15.58 | 15.52 | ||
Support 4 (S4) | 15.15 |